3 Semaglutide (Wegovy) Efficacy: In the STEP 1 trial involving adults with overweight or obesity without diabetes, those taking Wegovy 2.4 mg once weekly for 68 weeks achieved an average weight loss of approximately 14.9%, compared to 2.4% in the placebo group
Patients pay about $100 to $450 a month, compared with list prices of roughly $1,000 to $1,400 for Lilly and Novo Nordisk products
Option 1: Protein-Packed Oatmeal Prepare one-half cup of steel-cut oats with water or unsweetened almond milk
NICE guidelines recommend that any changes to diabetes medications should be made under healthcare supervision with appropriate follow-up and HbA1c monitoring within three months
Reuters reported that the approval strengthens Novo Nordisks position against competitors, including Eli Lilly, which has an oral candidate still under review
Continuing your protocol through plateaus is critical